Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review

Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review

This review article explores the evolving landscape of Molecular Radiotherapy (MRT), emphasizing Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumours (NETs). The primary focus is on the transition from β-emitting radiopharmaceuticals to α-emitting agents in PRRT, offering a critic...

Full description

Bibliographic Details
Main Authors: Paul M. D. Gape, Michael K. Schultz, Graeme J. Stasiuk, Samantha Y. A. Terry
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Pharmaceuticals
Subjects:
molecular radiotherapy
targeted radionuclide therapy
targeted alpha therapy
peptide receptor radionuclide therapy
neuroendocrine tumours
Online Access:https://www.mdpi.com/1424-8247/17/3/334

Internet

https://www.mdpi.com/1424-8247/17/3/334

Similar Items